Exalenz's device to diagnose H. pylori bacteria is released

07/16/2013 | Reuters

Exalenz Bioscience said its BreathID Hp device, the latest addition to its BreathID product portfolio, is available commercially. The device uses a patient's breath to detect Helicobacter pylori bacteria, which is often tied to peptic ulcers and may also raise gastric-cancer risk. The test can generate results in 10 to 15 minutes.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD